Search

everythinglearnresearchcommunity

for

Search:↓

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Blocking certain immune signals can reduce skin damage from radiation therapy.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Ruxolitinib cream may help treat severe hair loss in children.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Co-trimoxazole may help treat autoimmune diseases.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Biosimilars lower costs but don't significantly improve access.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors show promise for treating alopecia areata but their effectiveness and safety are still debated.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.